Ergoteles’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,579
Closed -$482K 894
2023
Q2
$482K Sell
3,579
-14,040
-80% -$1.81M 0.02% 651
2023
Q1
$2.23M Buy
17,619
+14,387
+445% +$1.86M 0.09% 241
2022
Q4
$395K Buy
+3,232
New +$427K 0.01% 798
2022
Q3
Sell
-7,400
Closed -$960K 2066
2022
Q2
$960K Sell
7,400
-1,746
-19% -$219K 0.03% 558
2022
Q1
$1.25M Buy
+9,146
New +$1.31M 0.05% 369
2021
Q4
Sell
-6,600
Closed -$957K 1657
2021
Q3
$957K Buy
6,600
+600
+10% +$81.2K 0.04% 391
2021
Q2
$788K Buy
6,000
+2,371
+65% +$305K 0.02% 594
2021
Q1
$455K Buy
+3,629
New +$441K 0.01% 502
2020
Q4
Sell
-3,000
Closed -$293K 951
2020
Q3
$293K Buy
+3,000
New +$294K 0.04% 354

Other funds holding BCPC

Ergoteles's BCPC Position: Q3 2023 in Review

Ergoteles sold out of Balchem Corp (BCPC) in Q3 2023, closing a stake of 3,579 shares — an estimated $482K sold.

Ergoteles first reported a position in BCPC in Q3 2020 and held it in 9 quarters. The position peaked at $2.23M in Q1 2023. 293 funds tracked by Wall St. Rank hold BCPC as of Q3 2023.

  • Ergoteles reported no remaining Balchem Corp position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 3,579 Balchem Corp shares in Q3 2023, an estimated $482K.
  • Ergoteles first reported a position in Balchem Corp in Q3 2020 and held it in 9 quarters.
  • Ergoteles's Balchem Corp position peaked at $2.23M in Q1 2023.
  • 293 funds tracked by Wall St. Rank held Balchem Corp as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.